BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 28747339)

  • 1. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
    Sohn BH; Hwang JE; Jang HJ; Lee HS; Oh SC; Shim JJ; Lee KW; Kim EH; Yim SY; Lee SH; Cheong JH; Jeong W; Cho JY; Kim J; Chae J; Lee J; Kang WK; Kim S; Noh SH; Ajani JA; Lee JS
    Clin Cancer Res; 2017 Aug; 23(15):4441-4449. PubMed ID: 28747339
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
    Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
    Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.
    Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J
    PeerJ; 2021; 9():e11481. PubMed ID: 34046266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy.
    Nemtsova MV; Kuznetsova EB; Bure IV
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
    Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
    Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
    Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
    Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
    World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
    Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer molecular classification based on immunohistochemistry and in-situ hybridisation and mortality.
    Eskuri M; Birkman EM; Kauppila JH
    Histopathology; 2024 May; ():. PubMed ID: 38715404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer.
    Cai L; Sun Y; Wang K; Guan W; Yue J; Li J; Wang R; Wang L
    Front Oncol; 2020; 10():1269. PubMed ID: 32850385
    [No Abstract]   [Full Text] [Related]  

  • 12. Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
    Kohlruss M; Krenauer M; Grosser B; Pfarr N; Jesinghaus M; Slotta-Huspenina J; Novotny A; Hapfelmeier A; Schmidt T; Steiger K; Gaida MM; Reiche M; Bauer L; Ott K; Weichert W; Keller G
    Br J Cancer; 2021 Dec; 125(12):1621-1631. PubMed ID: 34671125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
    Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
    Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
    Kim Y; Cho MY; Kim J; Kim SN; Oh SC; Lee KA
    Oncotarget; 2017 Sep; 8(41):69888-69905. PubMed ID: 29050249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEMoS: a deep learning-based ensemble approach for predicting the molecular subtypes of gastric adenocarcinomas from histopathological images.
    Wang Y; Hu C; Kwok T; Bain CA; Xue X; Gasser RB; Webb GI; Boussioutas A; Shen X; Daly RJ; Song J
    Bioinformatics; 2022 Sep; 38(17):4206-4213. PubMed ID: 35801909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
    Moore A; Hikri E; Goshen-Lago T; Barkan T; Morgenstern S; Brook E; Maderer A; Roth W; Gordon N; Kashtan H; Brenner B; Moehler M; Aharon IB
    BMC Cancer; 2020 Jan; 20(1):34. PubMed ID: 31937281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
    Yoon JY; Sy K; Brezden-Masley C; Streutker CJ
    PLoS One; 2019; 14(12):e0224812. PubMed ID: 31790410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy.
    Rodriquenz MG; Roviello G; D'Angelo A; Lavacchi D; Roviello F; Polom K
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32403403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
    J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity.
    Park C; Cho J; Lee J; Kang SY; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim ST; Park SH; Park JO; Kang WK; Sohn I; Jung SH; Kang MS; Kim KM
    Oncoimmunology; 2017; 6(11):e1356150. PubMed ID: 29147610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.